Fine-mapping HLA-II haplotypes in Alzheimer's disease and healthy longevity reveals distinct associations with microglial HLA-II load and neuropathology
Alvarez Sirvent, D.; Luimes, M. C.; Tesi, N.; Rohde, S. K.; Salazar, A. N.; Bijker, L. J.; van Schoor, N. M.; Tijms, B. M.; Vijverberg, E. G. B.; Strijbis, E. M. M.; Hoekstra, E. J.; Holtman, I. R.; van der Lee, S. J.; Hulsman, M.; Holstege, H.
Show abstract
Human leukocyte antigen (HLA) class II variation is implicated in Alzheimer's disease (AD) and longevity, but its mechanisms within the major histocompatibility complex remain unclear. We fine-mapped seven independent HLA-II haplotypes in 6,053 individuals (443 cognitively healthy centenarians [CHCs], 3,219 population controls, 2,391 AD patients). Three haplotypes overlapped previous AD and lifespan signals. Hap-B (DRB1*04subtypes) was protective, enriched in CHCs and controls versus AD, with its neuroprotective association with tau pathology replicated in an independent Netherlands Brain Bank cohort. Hap-R (DRB1*01:01) increased AD risk and reduced healthy longevity, with reduced microglial HLA-II activation. Hap-Y (DRB1*15:01) showed increased microglial HLA-II activation in post-mortem brain tissue, independent of quantitative AD neuropathology. These findings indicate distinct HLA-II haplotypes shape AD susceptibility and healthy longevity through separate mechanisms, linking HLA architecture to brain immune states beyond classical neuropathology.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- From aging to Alzheimer's disease: concordant brain DNA methylation changes in late life 94%
- Identification and drug-induced reversion of molecular signatures of Alzheimers disease onset and progression in AppNL-G-F, AppNL-F and 3xTg-AD mouse models 93%
- Structural variants linked to Alzheimer’s Disease and other common age-related clinical and neuropathologic traits 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.